Thank you

This live web event has ended. Thank you for attending.

Description

Identification of genetic mutations in
HR deficient breast, ovarian, prostate
cancer using QIAseq HRD panel

Why should you register now for this webinar?
Listen to a national thought leader discuss how QIAseq HRD panel is used in the
identification of genetic mutations in HR deficient breast, ovarian and prostate cancer
Brought to you by: CAP TODAY
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Presenter: Nils Hartmann, PhD

What will this webinar empower you to do?
Understand how to implement a workflow identifying gene mutations in breast, ovarian
and prostate cancer
Discuss comparison of the QIAseq HRD panel with QIAseq BRCA Panels for profiling gene mutations from FFPE tumor tissue
Review analysis and review of panel results using a full Sample to Insight workflow
using CLC workbench
Q&A with our distinguished presenter

CAP TODAY does not endorse any of the products or services named within.
The webinar is made possible by a special educational grant from Qiagen.